This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Go down here......i'm Genotype 3a...should i put off treatment to wait for VX-950? - niceguy2007 07/09/2006
And also go down to....... What are long lasting side effects of treatment? Pozzy 07/08/06.
Also schering-plough is also working on a new one.
Both of these have been FDA fastracked.
Should be a trial in your area PhaseII starting real soon.
Cin
couldn't think of a nickname
07/09/2006
C42 . I checked in, and thought I could help some in the drug development area.
1. VX-950 is being tested in Europe WITHOUT Riba. The company is not convinced riba adds much, as just 950 and IFN got 5.5 logs in 2 weeks anyway. In fact, and this is just my take, in the study they got 12 out of 12 neg. in 28 days, but 1 relapsed while on IFN/Riba maintenence, it would appear (to me anyway) that 950 was needed longer, and riba did not pick up the slack. Of course, patient 12 might have virus resistant to IFN for all we know.
2. Resistance: VX-950 does develop a resistant strain, the A156T strain. 950 does render it less fit. My guess is, it has not been a major problem, and A156T is sensitive to IFN anyway.
3. NM 283 could have a problem if it gets tested with riba. Both are nucleoside analogs, and Piper Jaffrey notes that they might have synergistic GI side effects. No one wants riba included, and even if the next gen of drugs are approved with it, I wonder if some might opt out of it anyway. I would.
4.ITMN has a PI that preclinically, is supposed to be much better than 950, and does not have that mutant strain issue of A156T. Maybe a poss. future combo? Way too early to speculate.
What happens in the clinic is an open question. IMHO any new therapy without IFN would right now need to be a combo of new drugs, not necessarily 1 alone.
5. VRTX has a second gen. compound that is 2 years behind 950.
Companies do this because the first to market is rarely the best over time. They can learn a lot from the first one, and improve on either liver concentrations, dosing, etc. Not much has been said about this, but they are working on it.They have since said this publicly, but I pretty much new it based on this exchange with the company I had a few months ago:
Me: "Is VRTX working on a next gen to 950?"
VRTX" "We have an active and productive drug development program". I saw that as a yes, having talked to various companies for many years, and knowing their language.
6. SGP has a PI, and they hoped to get into p3 later this year, but I doubt that will happen. They recently added a higher dose to their p2, and I don't believe preparations are in place for a p3 that soon anyway.
7. BMY has a PI. A privately held biotech has a PI in development. For what we do know about drugs in development, there is a lot we don't know. But, the next gen should certainly lead to much shorter tx times, which hopefully will lead to less long term side effects.
The faster route to U.S. FDA approval is to test it with both Peg and Riba. In the Europe Prove II trials it is being tested with peg but WITHOUT riba.
What is especially annoying about the incorrect characterization of my quote is that my whole point was that it DIDN'T matter how Vertex was going to be used -- with peg and riba, with just peg, or by itself -- the fact that the treatment time could potentially be shorter hopefully will result in less sides.
How this turned into a statment that I somehow said Vertex will hit the market without ribavirin and I'm therefore deceiving new people in the discussion group is totally beyond me. I posted relevant links in the post below, but again, go here: http://www.vrtx.com/Pressreleases2006/pr052306.html and then scroll down to PROVE II study.
CTON -- didn't get a chance to say "hello" below. Thanks for taking the time to visit and keeping us informed about how the newer treatments are going.
-- Jim
I agree with you it is a shi**y choice all the way around.
I am 3a and had a VL of 400 at week 4 and was UND by week 12, I did 24 weeks on 800 riba and full dose IFN never missed a dose and relapsed. I did not get a biopsy, my doctor didnt feel it was warranted Ultrasound was clear. My enzymes were never over 100 and normalized by week 4. I am now on the second round of tx, this time for a year. 72 weeks in all.
This round I was UND at week 4 and so far am still UND.
I started on 800 mg of nm283 and the prefilled pegasys syringe. I agree with the person he made the statements about gastro problems bc I had them bad until my dose of NM283 was cut to 400mg. I can't imagine what it's going to be like in the new trial with ribavin/nm283/pegasys. If you don't have insurance and you are in a hurry to treat, you might try it. My nurse said they're paying $1000 for that trial.
I hope you start to get rid of those sides soon. When I do check in, I like to see how you, and everyone else are feeling, and everyday I pray for those I have come to know in here for a cure, and recovery from it.
Funny thing is, my post below was probably better done in this thread, and even though this thread is at the top of the page, I just scrolled down and the thread on long term side effects caught my eye, as that is a concern to me, and I prefer to read real experiences.
But, it was cut-and pasted anyway, so it's all good LOL
http://www.eurekalert.org/pub_releases/2006-07/jws-ssh070606.php
Alady: thanks to you too for posting your experiences here, I'm sure we are all curious about the new drugs, and it's very good of you to tell us what's going on with you, be well!
These next several months, and this first part of the p2B trial for 950 are very important. Good 3 month results could help move the process along. If not, it still looks like it is under 3 years for that.
I was pleased they chose J&J to partner with outside of N. Amer. J&J's subsid. also has a compound in development that would be considered second gen, but it is actually behind VRTX'S. The efforts are certainly being made by the drug companies. Let's hope they bear fruit ASAP.
statin find? whats that? im in Japan and i never heard of that!
And I haven't forseen a good man in awhile! Ha ha ha! Couldn't resist that one, hope you have a good day Nice Guy, as another poster Jim and I will attest, a diet of Japanese food is some of the most healthiest cuisine on the planet...as long as you don't include Fugu, the pufferfish, but maybe Jim is a little more intrepid than I am...ha ha! wow, am I silly this morning! I think I better go drink some green tea or something, hope we all have a good week!!!!
Here is the link talking about statins and hep c....
http://tinyurl.com/mh2a6